Observational studyBMC cancer2021

Nanoliposomal irinotecan plus fluorouracil and folinic acid as a second-line treatment option in patients with metastatic pancreatic ductal adenocarcinoma: a retrospective cohort study.

Se Jun Park et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.